USE OF METRONIDAZOLE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING PATHOLOGIES RELATED TO THE B-TYPE RECEPTOR OF INTERLEUKIN 8 AND/OR TO A PACAP TYPE 1 RECEPTOR

摘要

The invention relates to use of metronidazole for the preparation of a pharmaceutical composition for treating pathologies involving at least one receptor chosen from the group comprising the IL-8RB receptor and the PAC-1 receptor.